中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 3
Mar.  2011

New strategy for the treatment of hepatic fibrosis

  • Published Date: 2011-03-20
  • Hepatic fibrosis is the common pathological change of chronic liver diseases, and reversal of fibrosis can prevent the progression of most chronic liver diseases.The activation of hepatic stellate cells (HSCs) is considered as the central event of hepatic fibrosis, thus the traditional therapy for hepatic fibrosis was targeting to HSC and have achieved substantial efficacy in animal experiments.However, recent studies have indicated that the activation of HSCs also contributes to the hepatocyte proliferation and live regeneration.Hepatocyte nuclear factors (HNFs) consist of a group of transcription factors, which are critical for the hepatocyte differentiation and functional maintenance.Forced expression of HNFs could reduce the secretion of ECM, promote hepatocyte regeneration and improve liver function.Therefore, upregulation of HNFs presents as an ideal strategy for the treatment of hepatic fibrosis.

     

  • [1]Bataller R, Brenner DA.Liver fibrosis[J].J Clin Invest, 2005, 115 (2) :209-218.
    [2]Poynard T, Bedossa P, Opolon P.Natural history of liver fibrosis progression in patients with chronic hepatitis C.The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups[J].Lancet, 1997, 349 (9055) :825-832.
    [3]Boccato S, Pistis R, Noventa F, et al.Fibrosis progression in initially mild chronic hepatitis C[J].J Viral Hepat, 2006, 13 (5) :297-302.
    [4]Friedman SL.Hepatic stellate cells[J].Prog Liver Dis, 1996, 14:101-130.
    [5]Friedman SL, Roll FJ, Boyles J, et al.Hepatic lipocytes:the principal collagen-producing cells of normal rat liver[J].Proc Natl Acad Sci U S A, 1985, 82 (24) :8681-8685.
    [6]Friedman SL.Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury[J].J Biol Chem, 2000, 275 (4) :2247-2250.
    [7]Friedman SL.Hepatic stellate cells:protean, multifunctional, and enigmatic cells of the liver[J].Physiol Rev, 2008, 88 (1) :125-172.
    [8]谢渭芬.肝纤维化治疗策略探讨[J].中华消化杂志, 2004, 24 (10) :577-578.
    [9]Zhong W, Shen WF, Ning BF, et al.Inhibition of extracellular signal-regulated kinase 1 by adenovirus mediated siRNA attenuates hepatic fibrosis in rats[J].Hepatology, 2009, 50 (5) :1524-1536.
    [10]Hu PF, Chen H, Zhong W, et al.Adenovirus-mediated transfer of siRNA against PAI-1 mRNA ameliorates hepatic fibrosis in rats[J].J Hepatol, 2009, 51 (1) :102-113.
    [11]Chen SW, Chen YX, Zhang XR, et al.Targeted Inhibition of platelet-derived growth factor receptorβsubunit in hepatic stellate cells ameliorates hepatic fibrosis in rats[J].Gene Therapy, 2008, 15 (21) :1424-1435.
    [12]Passino MA, Adams RA, Sikorski SL, et al.Regulation of hepatic stellate cell differentiation by the neurotrophin receptor p75NTR[J].Science, 2007, 315 (5820) :1853-1856.
    [13]Benten D, Kumaran V, Joseph B, et al.Hepatocyte transplantation activates hepatic stellate cells with beneficial modulation of cell engraftment in the rat[J].Hepatology, 2005, 42 (5) :1072-1081.
    [14]Kalinichenko VV, Bhattacharyya D, Zhou Y, et al.Foxf1+/-mice exhibit defective stellate cell activation and abnormal liver regeneration following CCl4 injury[J].Hepatology, 2003, 37 (1) :107-117.
    [15]Lorenzini S, Bird TG, Boulter L, et al.Characterisation of a ste-reotypical cellularand extracellular adult liver progenitor cell niche in rodents and diseased human liver[J].Gut, 2010, 59 (5) :645-654.
    [16]Soto-Gutierrez A, Kobayashi N, Rivas-Carrillo JD, et al.Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes[J].Nat Biotechnol, 2006, 24 (11) :1412-1419.
    [17] Deng X, Chen YX, Zhang X, et al.Hepatic stellate cells modulate the differentiation of bone marrow mesenchymal stem cells into hepatocyte-like cells[J].J Cell Physiol, 2008, 217 (1) :138-144.
    [18]Pintilie DG, Shupe TD, Oh SH, et al.Hepatic stellate cells'involvement in progenitor-mediated liver regeneration[J].Lab Invest, 2010, 90 (8) :1199-1208.
    [19]Kordes C, Sawitza I, Muller-Marbach A, et al.CD133+hepatic stellate cells are progenitor cells[J].Biochem Biophys Res Commun, 2007, 352 (2) :410-417.
    [20]Yang L, Jung Y, Omenetti A, et al.Fate-mapping evidence that hepatic stellate cells are epithelial progenitors in adult mouse livers[J].Stem Cells, 2008, 26 (8) :2104-2113.:
    [21]Odom DT, Zizlsperger N, Gordon DB, et al.Control of¨pancreas and liver gene expression by HNF transcription factors[J].Science, 2004, 303 (5662) :1378-1381.
    [22]Parviz F, Matullo C, Garrison WD, et al.Hepatocyte nuclear factor 4αcontrols the development of a hepatic epithelium and liver morphogenesis[J].Nat Genet, 2003, 34 (3) :292-296.
    [23]Li J, Ning G, Duncan SA.Mammalian hepatocyte differentiation requires the transcription factor HNF-4a[J].Genes Dev, 2000, 14 (4) :464-474.
    [24]Hayhurst GP, Lee, Lambert G, et al.Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis[J].Mol Cell Biol, 2001, 21 (4) :1393-1403.
    [25]Yin C, Lin Y, Zhang X, et al.Differentiation Therapy of Hepatocellular Carcinoma in Mice with Recombinant Adenovirus Carrying Hepatocyte Nuclear Factor-4αGene[J].Hepatology, 2008, 48 (5) :1528-1539.
    [26]Yue HY, Yin C, Hou JL, et al.Hepatocyte nuclear factor 4αattenuates hepatic fibrosis in rats[J].Gut, 2010, 59 (2) :236-246.
    [27]Ning BF, Ding J, Yin C, et al.Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma[J].Cancer Res, 2010, 70 (19) :7640-7651.
    [28]Odom DT, Zizlsperger N, Gordon DB, et al.Control of pancreas and liver gene expression by HNF transcription factors[J].Science, 2004, 303 (5662) :1378-1381.
  • Relative Articles

    [1]Yu WANG, Min WANG, Guanhua ZHANG, Fuliang HE, Xiaojuan OU, Jidong JIA. Clinical diagnosis, staging, and therapeutic principles of liver cirrhosis[J]. Journal of Clinical Hepatology, 2021, 37(1): 17-21. doi: 10.3969/j.issn.1001-5256.2021.01.004
    [2]Zhao WenShan, Xie Wen. Clinical assessment of the reversal of liver cirrhosis: “Point of return”[J]. Journal of Clinical Hepatology, 2019, 35(4): 724-727. doi: 10.3969/j.issn.1001-5256.2019.04.005
    [3]Chen YongPeng, Liang XieEr. Radiological evaluation of the reversal of liver fibrosis and cirrhosis[J]. Journal of Clinical Hepatology, 2019, 35(4): 720-723. doi: 10.3969/j.issn.1001-5256.2019.04.004
    [4]Liu TianHui. Serological assessment of the reversal of liver fibrosis and cirrhosis[J]. Journal of Clinical Hepatology, 2019, 35(4): 714-719. doi: 10.3969/j.issn.1001-5256.2019.04.003
    [5]Tang ChengWei. Work-up for diagnosis and treatment of liver cirrhosis: convention and development[J]. Journal of Clinical Hepatology, 2016, 32(2): 201-202. doi: 10.3969/j.issn.1001-5256.2016.02.001
    [6]Han Tao. Acute-on-chronic liver failure due to bacterial infection in liver cirrhosis: causes and management[J]. Journal of Clinical Hepatology, 2015, 31(9): 1415-1417. doi: 10.3969/j.issn.1001-5256.2015.09.012
    [7]Zhang JingWen, Shi YongQuan, Han Ying. Progress in treatment of liver cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(3): 465-468. doi: 10.3969/j.issn.1001-5256.2015.03.037
    [8]Xie WeiFen, Ceng Xin. Controversial problems in management of cirrhotic ascites[J]. Journal of Clinical Hepatology, 2014, 30(7): 601-603. doi: 10.3969/j.issn.1001-5256.2014.07.006
    [9]Lu LunGen, Li ZhengHong. Diagnosis and assessment of liver cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(7): 577-579. doi: 10.3969/j.issn.1001-5256.2014.07.001
    [10]Wu JianJin, Yao DingKang. Recent advances in understanding the relations between liver cirrhosis and sleep disorders[J]. Journal of Clinical Hepatology, 2013, 29(5): 397-400.
    [11]Lu LunGen, Li ZhengHong. Recent research on liver fibrosis and cirrhosis[J]. Journal of Clinical Hepatology, 2013, 29(5): 321-323.
    [12]Wei SiChen, Zheng GuoQi. Role of adipokine in the pathogenesis of cirrhosis of the liver[J]. Journal of Clinical Hepatology, 2012, 28(1): 78-81.
    [13]Chen Jing, Liu XiaoYan, Hu JinHua, Duan XueZhang, He WeiPing, Wang HuiFen, Xin ShaoJie. Clinical analysis of 24 cases of congenital hepatic fibrosis[J]. Journal of Clinical Hepatology, 2011, 27(10): 1041-1043.
    [14]Cao YuNing, Li SenLin. Research in the progress of non-invasive diagnosis of liver fibrosis[J]. Journal of Clinical Hepatology, 2011, 27(2): 214-217.
    [15]Qiu Ling, Hu YuLin. Recent status and prospect of ascites treatment in cirrhosis patients[J]. Journal of Clinical Hepatology, 2010, 26(6): 663-665.
    [16]Wang CaiSheng. Progress of diagnosis in liver fibrosis[J]. Journal of Clinical Hepatology, 2010, 26(6): 666-668.
    [18]Li XiaoFeng, Yang XiaoMing, Zhu JianMin, Wang JiXian. The relation between cirrhosis and GERD[J]. Journal of Clinical Hepatology, 2000, 16(4): 243-244.
    [19]Shang Jia, Wang XiuQi, Jin Xiu, Li YuKui, Li XiuLing. The Targets Hyperfibrinolysis Influence the Prognosis in Cirrhosis Patients[J]. Journal of Clinical Hepatology, 2000, 16(1): 35-36.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (3426) PDF downloads(1446) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return